A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.
Saved in:
| Title: | A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy. |
|---|---|
| Authors: | Chen, Zude1,2 (AUTHOR), Yang, Xiaoshuang3 (AUTHOR), Chen, Zugen1 (AUTHOR), Li, Minzhao1 (AUTHOR), Wang, Wei4 (AUTHOR), Yang, Riwei1 (AUTHOR), Wang, Zuomin1 (AUTHOR), Ma, Yuxiang1 (AUTHOR), Xu, Yulong2 (AUTHOR), Ao, Shan1 (AUTHOR), Liang, Leqi1 (AUTHOR), Cai, Chao1 (AUTHOR), Wang, Changning2 (AUTHOR), Deng, Tuo1 (AUTHOR), Gu, Di1 (AUTHOR) sveong@163.com, Zhou, Hongqing1,4 (AUTHOR) 1113293685@qq.com, Zeng, Guohua1 (AUTHOR) gzgyzgh@vip.sina.com |
| Source: | BMC Medicine. 10/25/2023, Vol. 21 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-023-03094-0 |
